Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-03 Adawi Kamal Chief Financial Officer Sale −6,582 $2.05 $14K 93,418
2026-08-04 TAHL CINDY See Remarks Sale −38,800 $2.46 $95K 589,355
2026-08-04 Valamehr Bahram President and CEO Sale −43,947 $2.46 $108K 591,815
2026-06-12 Xu Yuan Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 EPSTEIN ROBERT S Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 Agarwal Shefali Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 ABERNETHY MATT Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 RASTETTER WILLIAM H Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 Hamill Laura Director Grant or award · Stock Option (Right to Buy) +175,800 175,800
2026-06-12 Redmile Group, LLC Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-06-12 Lee Michael Stewart Director Grant or award · Stock Option (Right to Buy) +87,900 87,900
2026-05-20 TAHL CINDY See Remarks Sale −25,590 $1.88 $48K 628,155
2026-05-20 Valamehr Bahram President and CEO Sale −28,946 $1.88 $54K 635,762
2026-05-06 TAHL CINDY See Remarks Option exercise +122,220 $1.32 $161K 609,301
2026-05-06 TAHL CINDY See Remarks Option exercise +44,444 $1.05 $47K 653,745
2026-05-06 TAHL CINDY See Remarks Option exercise · Stock Option (Right to Buy) −122,220 152,780
2026-05-06 TAHL CINDY See Remarks Option exercise · Stock Option (Right to Buy) −44,444 355,556
2026-05-05 EPSTEIN ROBERT S Director Option exercise +25,000 $1.69 $42K 36,331
2026-05-05 EPSTEIN ROBERT S Director Option exercise · Stock Option (Right to Buy) +25,000 0

Page 1 of 26 · 503 trades